# Novartis Pharmaceuticals Corp. – FDA Inspection, Sep 16, 2010

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/7ab36698-ba47-4012-98ac-cac9115a1b78
Source feed: FDA_Inspections

> FDA inspection 680379 of Novartis Pharmaceuticals Corp., September 16, 2010. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 680379
- Company Name: Novartis Pharmaceuticals Corp.
- Inspection Date: 2010-09-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 936188 - 2015-07-14
- FDA Inspection 866692 - 2014-02-11
- [FDA Inspection 811624 - 2012-12-19](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/229bd035-f48f-4dc4-b65a-35c52cc06b95)
- [FDA Inspection 764997 - 2012-01-31](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/a6ff6688-fb83-4e60-81c0-b8321b957f80)
- [FDA Inspection 704290 - 2010-12-21](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corp/2b81d150-e371-43c3-8aad-2a7cc5e026dc)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-corp/f61e16e5-6ca9-432d-a015-9e5a541a0674

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c